Eicosapentaenoic acid (EPA) treatment increased the ratio to arachidonic (EPA/AA) and reduced adhesion molecule expression in vascular endothelium during inflammation
Sign Up to like & getrecommendations! Published in 2023 at "European Journal of Preventive Cardiology"
DOI: 10.1093/eurjpc/zwad125.177
Abstract: Type of funding sources: Private company. Main funding source(s): Amarin Pharmaceutical, Inc. Elucida Research LLC. Omega-3 fatty acid (n3-FA) treatment reduces cardiovascular (CV) risk in relation to circulating EPA/AA ratios. Treatment with icosapent ethyl (IPE),… read more here.
Keywords: epa; epa ratio; treatment; treatment increased ... See more keywords